Bridgewater Associates’s Codexis CDXS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-18,666
Closed -$87K 747
2022
Q4
$87K Sell
18,666
-70
-0.4% -$384 ﹤0.01% 817
2022
Q3
$114K Sell
18,736
-878
-4% -$7.06K ﹤0.01% 861
2022
Q2
$205K Buy
19,614
+564
+3% +$7.07K ﹤0.01% 973
2022
Q1
$393K Buy
19,050
+5,670
+42% +$117K ﹤0.01% 915
2021
Q4
$418K Buy
+13,380
New +$440K ﹤0.01% 663

Other funds holding CDXS

Bridgewater Associates's CDXS Position: Q1 2023 in Review

Bridgewater Associates sold out of Codexis (CDXS) in Q1 2023, closing a stake of 18,666 shares — an estimated $87K sold.

Bridgewater Associates first reported a position in CDXS in Q4 2021 and held it in 5 quarters. The position peaked at $418K in Q4 2021. 147 funds tracked by Wall St. Rank hold CDXS as of Q1 2023.

  • Bridgewater Associates reported no remaining Codexis position as of Q1 2023 after selling out during the quarter.
  • Bridgewater Associates sold 18,666 Codexis shares in Q1 2023, an estimated $87K.
  • Bridgewater Associates first reported a position in Codexis in Q4 2021 and held it in 5 quarters.
  • Bridgewater Associates's Codexis position peaked at $418K in Q4 2021.
  • 147 funds tracked by Wall St. Rank held Codexis as of Q1 2023.

Based on Bridgewater Associates's 13F filing for Q1 2023, filed 12 May 2023.